Tumeurs solides

TITRE (EN) Spatially Fractionated Radiation (SFR) Therapy as Palliative Radiation for Patients With Advanced and Symptomatic Tumors
PROTOCOLE ID GRID
CLINICAL TRIAL.gov ID NCT02333110
TYPE(S) DE CANCER Tumeurs solides
PHASE
TYPE D'ÉTUDE Support
INSTITUTION CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL
3755 rue de la Côte Ste. Catherine
(514) 340-8222
VILLE Montréal
INVESTIGATEUR(RICE) PRINCIPAL(E) Té Vuong
COORDONATEUR(RICE) Harielle Lamarre
hlamarre@jgh.mcgill.ca
514-340-8222 poste 26199
STATUT  Actif en recrutement
CRITÈRES D'ÉLIGIBILITÉ (EN)
  • Patient with histologically or cytologically confirmed malignancy. All malignant histologies/cytologies are eligible.
  • Patient with bulky tumor (larger than 8cm), or with a tumor known to be resistant to radiation (eg. Melanoma, hypernephroma, sarcoma), or with a tumor previously irradiated with a palliative intent requiring more than 1 fraction of radiation
  • Patient planned to undergo palliative radiation therapy treatments to one of the following 5 sites: extremities, neck, chest, abdomen and pelvis
  • WHO performance status of 0-2
  • Aged 18 years or older
  • Ability to sign and understand an informed consent form
CRITÈRES D'EXCLUSION (EN)
  • Potentially curable patient
  • Previous palliative radiation with hypofractionation
  • Tumor located near the spinal cord or in the brain
  • Pregnant or nursing woman